Cargando…
Inter- and Intra-Observer Agreement of PD-L1 SP142 Scoring in Breast Carcinoma—A Large Multi-Institutional International Study
SIMPLE SUMMARY: PD-L1 analysis in TNBC is essential for selecting patients eligible for immunotherapy. Limited data are available on pathologists’ concordance regarding PD-L1 assessment. Twelve pathologists of various expertise from three European countries digitally analysed 100 breast cancer core...
Autores principales: | Zaakouk, Mohamed, Van Bockstal, Mieke, Galant, Christine, Callagy, Grace, Provenzano, Elena, Hunt, Roger, D’Arrigo, Corrado, Badr, Nahla M., O’Sullivan, Brendan, Starczynski, Jane, Tanchel, Bruce, Mir, Yasmeen, Lewis, Paul, Shaaban, Abeer M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000421/ https://www.ncbi.nlm.nih.gov/pubmed/36900303 http://dx.doi.org/10.3390/cancers15051511 |
Ejemplares similares
-
Concordance of HER2-low scoring in breast carcinoma among expert pathologists in the United Kingdom and the republic of Ireland –on behalf of the UK national coordinating committee for breast pathology
por: Zaakouk, Mohamed, et al.
Publicado: (2023) -
MNA1.4.2 - Service Level Agreements in place
por: Members of EMI collaboration
Publicado: (Octo) -
Clinical, Histopathologic Features and Outcome of Breast Cancer in UK Women of Ethnic Origin
por: Zaakouk, Mohamed, et al.
Publicado: (2022) -
The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry‐equivocal invasive breast cancer
por: Katayama, Ayaka, et al.
Publicado: (2022) -
Inter‐observer agreement for the histological diagnosis of invasive lobular breast carcinoma
por: Christgen, Matthias, et al.
Publicado: (2021)